Screening: Assessment of current studies

Background. A major issue in decisions regarding screening women for breast cancer concerns ages of coverage, in particular, whether routine mass screening programs with mammography should cover women aged 40–49. Interpretation of results of studies on this question is affected by differences in design, adequacy of sample size, quality of mammography, period of follow‐up, and other methodologic and content issues.

[1]  N. Bundred.  The aetiology of periductal mastitis , 1993 .

[2]  S. Wall,et al.  Breast cancer screening with mammography: overview of Swedish randomised trials , 1993, The Lancet.

[3]  W. Hepburn,et al.  Randomisation by cluster and the problem of social class bias. , 1989, Journal of epidemiology and community health.

[4]  J. Hendriks,et al.  MAMMOGRAPHIC SCREENING AND BREAST CANCER MORTALITY: AGE-SPECIFIC EFFECTS IN NIJMEGEN PROJECT, 1975-82 , 1985, The Lancet.

[5]  A. Miller,et al.  Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .

[6]  S Shapiro,et al.  Periodic breast cancer screening in seven foreign countries , 1992, Cancer.

[7]  N. Day,et al.  EVALUATION OF SCREENING FOR BREAST CANCER IN A NON-RANDOMISED STUDY (THE DOM PROJECT) BY MEANS OF A CASE-CONTROL STUDY , 1984, The Lancet.

[8]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[9]  J. Kaldor,et al.  The benefits and risks of mammographic screening for breast cancer. , 1992, Epidemiologic reviews.

[10]  R. Tarone,et al.  Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. , 1988, Journal of the National Cancer Institute.

[11]  A. Huggins,et al.  Edinburgh trial of screening for breast cancer: mortality at seven years , 1990, The Lancet.

[12]  S Shapiro,et al.  Report of the International Workshop on Screening for Breast Cancer. , 1993, Journal of the National Cancer Institute.

[13]  A. Morrison,et al.  Breast cancer incidence and mortality in the breast cancer detection demonstration project [published errtum appears in J Natl Cancer Inst 1989 Oct 4;81(19):1513]. , 1988, Journal of the National Cancer Institute.

[14]  L. Tabár,et al.  The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. , 1989, Journal of epidemiology and community health.

[15]  Stefano Ciatto,et al.  A case‐control study of the efficacy of a non‐randomized breast cancer screening program in florence (Italy) , 1986, International journal of cancer.

[16]  A. Miller,et al.  Canadian National Breast Screening Study: assessment of technical quality by external review. , 1990, AJR. American journal of roentgenology.

[17]  D. Kopans.  The Canadian Screening Program: A Different Perspective , 1990 .

[18]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.

[19]  L. Baker,et al.  Breast cancer detection demonstration project: Five‐year summary report , 1982, CA: a cancer journal for clinicians.

[20]  Morrison.  Breast Cancer Incidence and Mortality in the Breast Cancer Detection Demonstration , 1988 .

[21]  A. Richardson,et al.  The effectiveness of breast cancer screening by mammography in younger women. , 1993, The Online journal of current clinical trials.